Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03478514
Title Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC
Indications

mantle cell lymphoma

Therapies

Ibrutinib + Palbociclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.